NATUREX : Filing of the 2011 Registration document
Avignon, May 2nd, 2011 - Naturex, world leader in speciality plant-based ingredients, has published its registration document for the year ended December 31st, 2011.2011 Registration document
The 2011 Registration document was filed with the French Financial Markets Authority (Autorité des Marchés Financiers) on April 26th, 2012 under the number D.12-0424.
This document includes :the annual financial report for the year ended December 31st, 2011 according to article L 451-1-2 of Code monétaire et financier ; the Chairman of the Board of Directors' Report on Corporate Governance, internal control and risk management ; the information related to the Statutory Auditors'fees ; the annual information document ; the resolutions proposed by the Board of Directors for the Ordinary and Extraordinary General Meeting of June 8th, 2012, for which the notice will be published in the Bulletin d'Annonces Légales et Officielles (BALO) within the legal time limits.
Copies of this document in French language are available free of charge, pursuant to applicable law, and can be downloaded from the company's web site www.naturex.com, under the « Investors » section, as well as on www.amf-france.org.
English translation of this document will be soon available.Financial agenda and next event 1st quarter results 2012 : 29th May 2012 Shareholders meeting : 8th June 2012 in Paris
If you would lik e to receive financial information about Naturex by e-mail, go to: www.naturex.com
Naturex has been listed since October 1996 on NYSE Euronext Paris, Compartment B (MidCaps)
Number of shares comprising the capital: 7,711,0766,953,768 ordinary shares (ISIN FR0000054694) 757,308 preferred shares (ISIN FR0010833251)
Naturex is a component of the CAC Small and Gaïa indexes.
Naturex is eligible for "long only" Deferred Settlement Service (SRD).
Naturex has implemented a Sponsored Level I American Depositary Receipt (ADR) program,
which trades on over-the-counter market in the United States under symbol NTUXY.
TICKER: NRX - Reuters : NATU.PA - Bloomberg : NRX:FP - DR Symbol: NTUXY
NATUREX is a global leader in specialty plant-based natural ingredients.
The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
NATUREX's head office is based in Avignon, France. The company employs more than 1,000 people with high-performance manufacturing operations across 15 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland), as well as in Morocco, the United States, Brazil, Australia and India. It also has a global presence through a dedicated network of sales offices in 21 countries (France, Italy, Spain, Morocco, the United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil, Mexico and India).
NATUREX's development is supported by positive underlying trends linked to a fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.
President and Chief Executive Officer
Tel.: +33 (0)4 90 23 96 89
Vice-President and Chief Financial Officer
Tel.: +33 (0)4 90 23 96 89
Tel.: +33 (0)4 90 23 78 28
|Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
Communiqués de mise à disposition de documents :
- Modalités de mise à disposition de document de référence ou de ses actualisations Communiqué intégral et original au format PDF :
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free